Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 1998

Diffuse idiopathic mesangial proliferative glomerulonephritis in re-biopsied patients. A quantitative study.

Marian Danilewicz, Ma¸gorzata Wągrowska-Danilewicz

Med Sci Monit 1998; 4(6): CR955-959 :: ID: 451731

Abstract

We examined fourteen patients with idiopathic mesangial proliferative glomerulonephritis (MPG) who received repeated renal biopsies and for whom both light and electron microscopy as well as immunofluorescence microscopy and full clinical data had been available. Morphometric investigations were performed by means of a computer image analysis system that evaluated the progression of the disease in re-biopsied patients, as well as demonstrated whether hypercellularity and mesangial increase could correlate with the degree of proteinuria. The morphometric study demonstrated that mean values of the total glomerular area, total amount of glomerular cells per total glomerular area and total amount of glomerular cells per unit of glomerular area were similar at the time of the initial biopsy and during re-biopsy. On the other hand mean values of mesangium (% of total glomerular area) were significantly decreased during re-biopsy, while mean values of relative interstitial volume were significantly increased at the time of the second biopsy. Correlations between mesangial hypercellularity as well as mesangial areas and proteinuria were during initial biopsy and at re-biopsy weak and insignificant. This data indicates that glomerular morphology does not correspond to the clinical outcome. Moreover, an increase of the relative interstitial volume demonstrates, that despite the clinical improvement at re-biopsy, MPG is a progressive glomerular disease which may lead towards renal failure.

Keywords: renal diseases, Glomerulonephritis, diagnesis, Biopsy, morphometry

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750